This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Agency for Science, Technology and Research. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ramanuj Dasgupta: Inventor in Singapore
Introduction
Ramanuj Dasgupta is an inventor based in Singapore and works at the Agency for Science, Technology and Research. His listed patent work concerns compounds that may modulate the interaction between β-catenin and T-cell factor 4 (TCF4).
Latest Patents
The provided information lists one patent for Dasgupta: “Heterocyclic Compounds as Modulators of Beta-Catenin / TCF4 Interaction.” The invention describes compounds and methods for inhibiting β-catenin or disrupting its interaction with TCF4. The proposed applications include research and potential treatment of cancer, neurodegenerative conditions, metabolic and cardiovascular diseases, fibrosis, and bone diseases. The patent describes compounds within a specified chemical formula and identifies several possible substituent groups.
Career Highlights
Dasgupta’s listed patent activity reflects work involving chemical compounds and a biological pathway relevant to disease research. The supplied information attributes 1 patent to him and identifies the Agency for Science, Technology and Research as his employer.
Collaborations
The provided information names Joo Leng Low and Weina Du as Dasgupta’s coworkers. Their inclusion here reflects the supplied coworker information and does not establish their specific roles in the patent.
Conclusion
Ramanuj Dasgupta is a Singapore-based inventor whose listed patent explores compounds targeting the β-catenin–TCF4 interaction, with potential relevance to several areas of disease research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile